Secukinumab efficacy and safety in indian patients with moderate-to-severe plaque psoriasis: Sub-analysis from FIXTURE, a randomized, placebo-controlled, phase 3 study

Title: Secukinumab efficacy and safety in Indian patients with moderate-to-severe plaque psoriasis: sub-analysis from FIXTURE (Full Year Investigative Examination of Secukinumab vs. Etanercept Using Two Dosing Regimens to Determine Efficacy in Psoriasis), a randomized, placebo-controlled, phase 3 st...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ramesh M Bhat, B Leelavathy, Sacchidanand S Aradhya, Maragondanahalli G Gopal, D. V. S. Pratap, Mir Mubashir, Putta Srinivas, Sushil Y Pande, Amit S Thavkar
Materialtyp: Artigo
Språk:Inglês
Publicerad: Wolters Kluwer Medknow Publications 2017-01-01
Serie:Indian Dermatology Online Journal
Ämnen:
Interleukin (IL)-17A
PASI 75
plaque psoriasis
secukinumab
Länkar:http://www.idoj.in/article.asp?issn=2229-5178;year=2017;volume=8;issue=1;spage=16;epage=24;aulast=Bhat
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk